2007: Pediatric Rheumatology: Clinical and Therapeutic Aspects I
Search or Browse by Day

Pediatric Rheumatology: Clinical and Therapeutic Aspects I

219
Neonatal-Onset Multisystem Inflammatory Disease (NOMID) and Weight Gain with IL-1 Blocking Therapy: Adiponectin’s Role in Control?
220
Safety and Efficacy Experience with Rilonacept (IL-1 Trap) in Adolescents with Cryopyrin-Associated Periodic Syndromes (CAPS)
221
Immunogenicity of Abatacept During a Double-blind Randomized Withdrawal Study in Patients with Juvenile Idiopathic Arthritis (JIA)
222
Alendronate Treatment of Pediatric Patients with Connective Tissues Disorders. A Ten Year Follow-Up Study
223
Pediatric Lupus Erythematosus: Long-Term Follow-Up and Prognostic Impact of Antiphospholipid Antibodies
224
Effective Treatment with IV Pamidronate in Chronic Recurrent Multifocal Osteomyelitis( CRMO)-Resolution of Pain, Normalization of Radiologic Abnormalities, and Improvement of Elevated Urine-N-Telopeptide (uNTX) : Case Series with 10 Patients
225
Etenercept is an Effective Therapeutic Option for Children with Juvenile Idiopathic Enthesitis Related Arthritis- Results from the German Etanercept Rergistry
226
Loss of Efficacy During Long-Term Infliximab Therapy for Sight-Threatening Childhood Uveitis
227
Development and Initial Validation of a New Composite Disease Activity Score for Juvenile Idiopathic Arthritis
228
Outcomes in the Initial Treatment of Knee Monoarthritis in Juvenile Idiopathic Arthritis: Results of a Decision Analysis Model
229
Localized Scleroderma Disease Activity Index (LoSDAI) and Global Assessments: A Pilot Study of Outcome Instruments
230
Thermography-Based Quantitative Measure of Disease Activity in Localized Scleroderma: A Proof-of-Concept Study
231
Outcome of Prospectively Followed Cohort from PRIDE (PR Interval and Dexamethasone Evaluation) in Congenital Heart Block (CHB)
232
Long-Term Psychosocial and Employment Outcomes of Children with Systemic Lupus Erythematosus
233
Macrophage Activation Syndrome (MAS) in Juvenile Systemic Lupus Erythematosus (JSLE): An Underrecognized Complication?
234
Urinary Proteomics: New Biological Markers for Systemic Lupus Erythematosus (SLE) Renal Disease
235
Neutrophil Gelatinase Associated Lipocalin (NGAL) in Plasma and Urine Change with Disease Activity in Pediatric Lupus (pSLE)
236
Health-Related Quality of Life (HRQoL) and Its Relationship to Patient Disease Course in Pediatric Systemic Lupus Erythematosus (pSLE)
237
Pediatric Class IV Lupus Nephritis: Time to Renal Remission Predicts Renal Pathology after One Year of Cyclophosphamide Infusions
238
Pediatric Class IV Lupus Nephritis (LN): Predictors of Renal Flare
239
Cachectic Obesity in Pediatric Systemic Lupus Erythematosus
240
Comparison of Inflammatory Mediator Profiles in Synovial Fluid from Pediatric Patients with Acute and Chronic Lyme Arthritis
241
Gene Expression Profiles in an Expanded Cohort of Pediatric Lyme Arthritis
242
Bone Morbidity in Glucocorticoid-treated Children with Chronic Rheumatic Disease (CRD)
243
Fitness and Fatigue in Pediatric SLE
244
Anti-NR-2 Antibodies are Prevalent in Childhood-Onset SLE (cSLE), but Do Not Predict Neurocognitive Dysfunction
245
Adapted Versions of the Sharp-Van Der Heijde Score are Reliable and Valid for Assessment of Radiographic Progression in Juvenile Idiopathic Arthritis
246
Early Diagnosis of Temporomandibular Joint Involvement in Juvenile Idiopathic Arthritis: A Pilot Study Comparing Clinical Examination and Ultrasound to Magnetic Resonance Imaging
247
High Prevalence of Temporomandibular Joint Arthritis at Disease Onset in Children with Juvenile Idiopathic Arthritis as Detected by MRI but not by Ultrasound
248
High prevalence of Algic-Dysfunctional Pathology of Masticatory Muscles in Children with Juvenile Idiopathic Arthritis (JIA)
249
Different Pattern of Il-1β Secretion and Response to Anti Il-1 Treatment in Patients with Systemic Onset Juvenile Idiopathic Arthritis (SoJIA)
250
Is Ultrasound a Valid Method for Assessment of Intra-Articular Cartilage Thickness in Children
251
Chronic Parotitis: An Underdiagnosed Feature of Juvenile Dermatomyositis
252
Clinical and Metabolic Characteristics of Acquired Lipodystrophy (LD) in Juvenile Dermatomyositis (JDM)
253
Long-Term Outcome and Quality of Life in Children with Chronic Recurrent Multifocal Osteomyelitis
254
Mortality Outcomes in Pediatric Rheumatology Conditions
255
The Interaction of the RGD Sequence of Vitronectin with Integrin in Membrane Attack Complex (MAC) Mediated Synovial Damage in Juvenile Idiopathic Arthritis (JIA)
See more of: ACR Abstract Submission Poster Sessions
<< Previous Session Level | Next Session Level >>